SCHEMBL16352134

SCHEMBL16352134

CC(=O)N(CCCP(C)(C)=O)OCc1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
ACP3 P15309 1/20 0.40
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
PARP10 Q53GL7 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
CDYL Q9Y232 1/20 0.37
SIRT5 Q9NXA8 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
FFAR1 O14842 1/20 0.36
AKR1B1 P15121 1/20 0.36
TACR1 P25103 1/20 0.36
BCHE P06276 1/20 0.36
CNR2 P34972 1/20 0.36
CTNNB1 P35222 1/20 0.36
MAPK8 P45983 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16363234 0.91 ACP3 (0.46) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL16363229 0.86 KMT2A (0.38) KMT2AMEN1ACP3ATML3MBTL1
SCHEMBL16352156 0.81 MEN1 (0.41) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL16352125 0.81 KMT2A (0.40) KMT2AL3MBTL1SMN1; SMN2FFAR1
SCHEMBL16352121 0.79 SLC1A3 (0.40) SLC1A3SLC1A2SLC1A1TACR1
SCHEMBL16352124 0.75 NR4A2 (0.40) L3MBTL1FFAR1AKR1B1
SCHEMBL16352132 0.74 RAB9A (0.38) L3MBTL1PARP10
SCHEMBL16352096 0.73 FDPS (0.40)
SCHEMBL16352131 0.73 MAOB (0.39) KMT2AMEN1L3MBTL1SMN1; SMN2
SCHEMBL16352119 0.72 RXRA (0.39) KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593136-B2 Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase THE GEORGE WASHINGTON UNIVERSITY (US) 2017-03-14 US disclosed
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE DCXR, G6PD, GRHPR KMT2A 4441/4885MEN1 4748/4885SLC1A3 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.